Ben Hendrix
Stock Analyst at RBC Capital
(3.61)
# 831
Out of 5,240 analysts
302
Total ratings
51.24%
Success rate
5.31%
Average return
Main Sectors:
Stocks Rated by Ben Hendrix
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AHCO AdaptHealth | Maintains: Outperform | $13 → $15 | $10.85 | +38.25% | 10 | May 11, 2026 | |
| PNTG The Pennant Group | Maintains: Outperform | $41 → $42 | $35.40 | +18.66% | 9 | May 8, 2026 | |
| CVS CVS Health | Maintains: Outperform | $93 → $107 | $97.37 | +9.89% | 12 | May 7, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Outperform | $28 → $31 | $27.48 | +12.83% | 15 | May 4, 2026 | |
| CI The Cigna Group | Maintains: Outperform | $333 → $337 | $300.57 | +12.12% | 15 | May 1, 2026 | |
| THC Tenet Healthcare | Maintains: Outperform | $277 → $236 | $196.51 | +20.10% | 13 | May 1, 2026 | |
| HUM Humana | Maintains: Sector Perform | $189 → $246 | $304.70 | -19.26% | 15 | Apr 30, 2026 | |
| UHS Universal Health Services | Maintains: Sector Perform | $216 → $190 | $171.23 | +10.96% | 11 | Apr 29, 2026 | |
| HCA HCA Healthcare | Maintains: Outperform | $593 → $534 | $428.34 | +24.67% | 19 | Apr 27, 2026 | |
| CHE Chemed | Maintains: Sector Perform | $422 → $436 | $421.87 | +3.35% | 17 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $361 → $400 | $401.27 | -0.32% | 19 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $39 | $38.79 | +0.54% | 1 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $11 → $9 | $6.87 | +31.00% | 7 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $9 → $3 | $1.84 | +63.04% | 9 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $13 | $9.81 | +32.59% | 6 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $20 | $14.09 | +41.94% | 11 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $19 → $17 | $16.47 | +0.18% | 12 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $47 → $52 | $40.67 | +27.86% | 4 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $11 | $8.40 | +30.95% | 9 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $5 → $3 | $1.13 | +166.67% | 8 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $206 → $222 | $177.08 | +25.37% | 10 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $31 | $25.64 | +20.90% | 4 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $13 → $17 | $13.04 | +30.37% | 17 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $12 → $5 | $0.86 | +481.26% | 7 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $134 → $139 | $95.21 | +45.99% | 15 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $6 → $5 | $2.90 | +72.71% | 5 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $478 | $399.55 | +19.63% | 9 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $109 → $105 | $73.14 | +43.56% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $110 → $125 | $107.54 | +16.24% | 12 | Apr 28, 2025 |
AdaptHealth
May 11, 2026
Maintains: Outperform
Price Target: $13 → $15
Current: $10.85
Upside: +38.25%
The Pennant Group
May 8, 2026
Maintains: Outperform
Price Target: $41 → $42
Current: $35.40
Upside: +18.66%
CVS Health
May 7, 2026
Maintains: Outperform
Price Target: $93 → $107
Current: $97.37
Upside: +9.89%
Acadia Healthcare Company
May 4, 2026
Maintains: Outperform
Price Target: $28 → $31
Current: $27.48
Upside: +12.83%
The Cigna Group
May 1, 2026
Maintains: Outperform
Price Target: $333 → $337
Current: $300.57
Upside: +12.12%
Tenet Healthcare
May 1, 2026
Maintains: Outperform
Price Target: $277 → $236
Current: $196.51
Upside: +20.10%
Humana
Apr 30, 2026
Maintains: Sector Perform
Price Target: $189 → $246
Current: $304.70
Upside: -19.26%
Universal Health Services
Apr 29, 2026
Maintains: Sector Perform
Price Target: $216 → $190
Current: $171.23
Upside: +10.96%
HCA Healthcare
Apr 27, 2026
Maintains: Outperform
Price Target: $593 → $534
Current: $428.34
Upside: +24.67%
Chemed
Apr 27, 2026
Maintains: Sector Perform
Price Target: $422 → $436
Current: $421.87
Upside: +3.35%
Apr 22, 2026
Maintains: Outperform
Price Target: $361 → $400
Current: $401.27
Upside: -0.32%
Mar 27, 2026
Initiates: Outperform
Price Target: $39
Current: $38.79
Upside: +0.54%
Mar 23, 2026
Maintains: Sector Perform
Price Target: $11 → $9
Current: $6.87
Upside: +31.00%
Mar 11, 2026
Maintains: Sector Perform
Price Target: $9 → $3
Current: $1.84
Upside: +63.04%
Mar 10, 2026
Maintains: Outperform
Price Target: $14 → $13
Current: $9.81
Upside: +32.59%
Mar 4, 2026
Maintains: Outperform
Price Target: $31 → $20
Current: $14.09
Upside: +41.94%
Mar 3, 2026
Downgrades: Sector Perform
Price Target: $19 → $17
Current: $16.47
Upside: +0.18%
Feb 27, 2026
Maintains: Outperform
Price Target: $47 → $52
Current: $40.67
Upside: +27.86%
Feb 24, 2026
Maintains: Outperform
Price Target: $18 → $11
Current: $8.40
Upside: +30.95%
Feb 11, 2026
Maintains: Sector Perform
Price Target: $5 → $3
Current: $1.13
Upside: +166.67%
Feb 9, 2026
Maintains: Outperform
Price Target: $206 → $222
Current: $177.08
Upside: +25.37%
Feb 2, 2026
Maintains: Outperform
Price Target: $30 → $31
Current: $25.64
Upside: +20.90%
Jan 29, 2026
Maintains: Outperform
Price Target: $13 → $17
Current: $13.04
Upside: +30.37%
Nov 26, 2025
Maintains: Sector Perform
Price Target: $12 → $5
Current: $0.86
Upside: +481.26%
Nov 7, 2025
Maintains: Outperform
Price Target: $134 → $139
Current: $95.21
Upside: +45.99%
Jul 25, 2025
Maintains: Outperform
Price Target: $6 → $5
Current: $2.90
Upside: +72.71%
Jun 4, 2025
Reiterates: Outperform
Price Target: $478
Current: $399.55
Upside: +19.63%
Apr 28, 2025
Maintains: Outperform
Price Target: $109 → $105
Current: $73.14
Upside: +43.56%
Apr 28, 2025
Maintains: Outperform
Price Target: $110 → $125
Current: $107.54
Upside: +16.24%